Advertisement
Loading...

Karyopharm Therapeutics Inc.

KPTI•NASDAQ
Healthcare
Biotechnology
$8.16
$0.10(1.24%)
U.S. Market opens in 1h 34m
Advertisement

Karyopharm Therapeutics Inc. (KPTI) Stock Overview

Explore Karyopharm Therapeutics Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap69.7M
P/E Ratio-0.92
EPS (TTM)$-16.40
ROE0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$5.53
3 Months$0.58
1 Year Target$0.00

KPTI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Karyopharm Therapeutics Inc. (KPTI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.92 and a market capitalization of 69.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.24%
5-Day Change
10.57%
1-Month Change
-5.77%
3-Month Change
-19.13%
6-Month Change
49.72%
Year-to-Date (YTD) Change
10.87%
1-Year Change
79.34%
3-Year Change
-77.43%
5-Year Change
-93.96%
All-Time (Max) Change
-96.61%

Contact Information

https://www.karyopharm.com
617 658 0600
85 Wells Avenue, Newton, MA, 02459

Company Facts

279 Employees
IPO DateNov 6, 2013
CountryUS
Actively Trading

Frequently Asked Questions